Sera Prognostics (SERA) Cash & Equivalents (2020 - 2026)

Sera Prognostics has reported Cash & Equivalents for 7 years, with the latest figure at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 20.17% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (down 20.17% YoY), and the FY2025 full-year result was $3.9 million, down 2.45% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $4.2 million, up from $3.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $64.1 million in Q1 2022, with the low at $2.7 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $17.5 million across 5 years, with a median of $5.0 million in 2025.
• Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 87.01% — and 2025, when it jumped 52.05%.
• Sera Prognostics' Cash & Equivalents stood at $29.9 million in 2022, then tumbled by 87.01% to $3.9 million in 2023, then gained by 4.2% to $4.0 million in 2024, then retreated by 2.45% to $3.9 million in 2025, then gained by 5.86% to $4.2 million in 2026.
• The last three Cash & Equivalents figures came in at $4.2 million (Q1 2026), $3.9 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.